Type in a country below to view the gender-responsiveness of its COVID-19 health policies and explore the policies reviewed
| Policy name: | FAQs |
| Issuing authority: | National Primary Health Care Development Agency |
| Policy date: | |
| Assessment of gender responsiveness | Gender Blind |
| Reference to human rights? | No |
| Reference to equity? | Yes |
| Policy name: | COVID-19 Mid-Action Review – Strategic Directions - See Risk Communication Pillar |
| Issuing authority: | Nigeria Centre for Disease Control |
| Policy date: | June 2020 |
| Policy type: | Communications guidelines |
| Assessment of gender responsiveness | Gender Blind |
| Reference to human rights? | No |
| Reference to equity? | No |
| Policy name: | National Technical Guidelines for Integrated Disease Surveillance and Response - See Section 7.2 Key Inter-Linked Principles for Effective Communication |
| Issuing authority: | Nigeria Centre for Disease Control |
| Policy date: | 11 July 1905 |
| Policy type: | Communications guidelines |
| Assessment of gender responsiveness | Gender Sensitive |
| Reference to human rights? | Yes |
| Reference to equity? | Yes |
| Policy name: | National Interim Guidelines for Clinical Management of COVID-19 |
| Issuing authority: | Nigeria Centre for Disease Control |
| Policy date: | 14 March 2020 |
| Assessment of gender responsiveness | Gender Blind |
| Reference to human rights? | No |
| Reference to equity? | No |
| Policy name: | COVID-19 Mid-Action Review – Strategic Directions - See Case Management Pillar |
| Issuing authority: | Nigeria Centre for Disease Control |
| Policy date: | June 2020 |
| Assessment of gender responsiveness | Gender Blind |
| Reference to human rights? | No |
| Reference to equity? | Yes |
| Policy name: | Infection Prevention and Control Recommendations during Health Care Provision for Suspected and Confirmed Cases of COVID-19 |
| Issuing authority: | Nigeria Centre for Disease Control |
| Policy date: | 1 September 2020 |
| Assessment of gender responsiveness | Gender Blind |
| Reference to human rights? | No |
| Reference to equity? | No |
| Policy name: | National Interim Guidelines for Clinical Management of COVID-19 - See Section 1.5 Overview Of PPE |
| Issuing authority: | Nigerian Government and Nigeria CDC |
| Policy date: | 14 March 2020 |
| Assessment of gender responsiveness | Gender Blind |
| Reference to human rights? | No |
| Reference to equity? | No |
| Policy name: | Equipment Recommendations During Health Care Delivery for Patients with Suspected or Confirmed COVID-19 Infection |
| Issuing authority: | Nigeria Centre for Disease Control |
| Policy date: | 29 February 2020 |
| Assessment of gender responsiveness | Gender Blind |
| Reference to human rights? | No |
| Reference to equity? | No |
| Policy name: | Rational Use of Personal Protective Equipment in the Care of COVID-19 Cases |
| Issuing authority: | Nigeria Centre for Disease Control |
| Policy date: | No date |
| Assessment of gender responsiveness | Gender Blind |
| Reference to human rights? | No |
| Reference to equity? | No |
| Policy name: | COVID-19 Mid-Action Review – Strategic Directions - See Surveillance Pillar |
| Issuing authority: | Nigeria Centre for Disease Control Government of Nigeria World Health Organisation |
| Policy date: | June2020 |
| Assessment of gender responsiveness | N |
| Reference to human rights? | No |
| Reference to equity? | No |
| Policy name: | National Technical Guidelines for Integrated Disease Surveillance and Response - See Section 11.52 COVID-19 |
| Issuing authority: | Nigeria Centre for Disease Control Government of Nigeria World Health Organisation |
| Policy date: | No date |
| Assessment of gender responsiveness | Y |
| Reference to human rights? | Yes |
| Reference to equity? | Yes |
